Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous ( SQ ) , once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily) , demonstrated superior weight loss compared to...
Fashion Icon Liu Wen Radiates Brilliance at Madame Tussauds Hong Kong Unveiling Event
HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Madame Tussauds Hong Kong, a brand under the Merlin Entertainment Group, proudly unveils the latest wax figure of internationally acclaimed model, Liu Wen. Visiting Madame Tussauds Hong Kong, Liu Wen...
MoonFox Analysis | From Significant Growth to Rational Cooling: The Study Tour Market Enters a Transitional Phase
About us: Aurora Mobile (NASDAQ: JG) established in 2011, is a leading customer engagement and marketing technology service provider in China. Its business includes notification services, marketing growth, development tools, and data products. As...
Hisense Scores Record-Breaking Black Friday Sales Abroad with Surge in Large Screen TV and Smart Home Innovation
QINGDAO, China, Dec. 16, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, demonstrated its global leadership in consumer electronics with record-breaking sales during the Black Friday period. The...
Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC) A Phase Ib Study of AC-101 for Ulcerative Colitis (UC) has been initiated in China AC-101 demonstrated a favorable safety and PK/PD...
Most Impactful Marketing Campaigns in 2024 Across APAC Celebrated at Prestigious MMA SMARTIES APAC 2024
SINGAPORE, Dec. 13, 2024 /PRNewswire/ -- The MMA SMARTIES APAC 2024 Awards honored an impressive 93 winning campaigns, presenting 37 Gold, 24 Silver, and 32 Bronze medals, along with 11 industry winners that showcased the best of what APAC has to...
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK,...
State Grid Kuitun Power Supply Company steadily promotes the construction of a new generation of centralized control system
KUITUN, China, Dec. 11, 2024 /PRNewswire/ -- Recently, State Grid Kuitun Power Supply Company successfully demonstrated the powerful functions of the new generation of centralized control system at Kuitun centralized control station. On December 11,...
Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer
Sunvozertinib, as a single agent, demonstrated promising antitumor activity and favorable safety profile in heavily pretreated patients with EGFR-mutated NSCLC who had developed resistance to EGFR TKI treatment SHANGHAI, Dec. 11, 2024 /PRNewswire/...
Weichai Energizes Global Markets through Strategic Partnerships and Innovation
WEIFANG, China, Dec. 11, 2024 /PRNewswire/ -- On December 10, the 2025 Weichai Global Partners Conference overseas session was held in Weifang, China, drawing global customers, partners and key stakeholders from the Middle East, Africa, and...